The strategy of covering the mouth and nose to avoid being infected with coronavirus and other airborne diseases may neglect the largest and weakest point of entry to the human body – the eyes – specialists from UNSW Sydney and ANU suggest.
A rise in vaccine-resistant bacteria shows the need for a new vaccine to fight childhood empyema after a spike in hospitalisations, a new UNSW study reveals.
Researchers from Australia and the United States have gained new insight into how SARS-CoV-2 interacts with cells, which has implications for how the virus may attempt to destabilise the host immune response.
People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk, a UNSW Sydney study has found.
This World Cancer Day, a range of UNSW Medicine & Health cancer researchers, clinicians and scientists are available for media interviews across all aspects of cancer, from prevention and detection to treatment and survivorship.
CHeBA Co-Director, Professor Henry Brodaty, along with an international research, has been awarded $400,000 to strengthen professional collaboration in dementia caregiver education and research.
A six-year study of older Australians in CHeBA’s Sydney Memory and Ageing Study has uncovered an Australian-first association between the impact of hearing loss on cognitive abilities and increased risk for dementia.
COVID has highlighted the differences in healthcare affordability across the globe, with a glimpse into what the future of medicine could look like if we don’t act.
People with enlarged fluid-filled spaces in the brain around small blood vessels may be more likely to develop dementia than people whose perivascular spaces are smaller, according to a new study led by CHeBA.
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
